This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Arbormentis LLC, Mggm LLC, University of Padova. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 2 Years Active: 2026
Title: Sara De Martin: Innovator in Opioid Modulation
Introduction
Sara De Martin is a prominent inventor based in Vigonza, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of structurally modified opioids. With a total of 2 patents, her work focuses on improving drug efficacy and safety.
Latest Patents
Sara's latest patents include innovative approaches to opioid modulation. One patent addresses "Structurally modified opioids for prevention and treatment of diseases and conditions." This invention aims to enhance the modulating activity at the NMDAR, offering improved pharmacokinetic (PK) and pharmacodynamic (PD) parameters compared to existing drugs. The structural modifications can be achieved through various synthetic processes, including de novo synthesis and modifications at intermediate steps.
Another significant patent involves "Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations." This invention utilizes serotonin (5-HT) receptor agonists and NMDAR modulating substances to treat various diseases and improve neural functions.
Career Highlights
Sara has worked with esteemed institutions, including the University of Padova and Arbormentis LLC. Her research has been pivotal in advancing the understanding of opioid modulation and its therapeutic applications.
Collaborations
Sara has collaborated with notable professionals in her field, including Andrea Mattarei and Andrea Cavalli. These partnerships have contributed to her innovative research and patent developments.
Conclusion
Sara De Martin is a trailblazer in the field of opioid modulation, with her patents reflecting a commitment to improving treatment options for various conditions. Her work continues to influence the landscape of pharmacology and drug development.